Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease

MLA

Serhan Sevim, et al. “Ultrasound-Guided versus ‘Blind’ Intraparotid Injections of Botulinum Toxin-A for the Treatment of Sialorrhoea in Patients with Parkinson’s Disease.” Clinical Neurology and Neurosurgery, vol. 106, Mar. 2004, pp. 93–96. EBSCOhost, https://doi.org/10.1016/j.clineuro.2003.10.012.

APA

Serhan Sevim, Derya Ümit Talas, M. Aral, Okan Dogu, & Demir Apaydin. (2004). Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease. Clinical Neurology and Neurosurgery, 106, 93–96. https://doi.org/10.1016/j.clineuro.2003.10.012

Chicago

Serhan Sevim, Derya Ümit Talas, M. Aral, Okan Dogu, and Demir Apaydin. 2004. “Ultrasound-Guided versus ‘Blind’ Intraparotid Injections of Botulinum Toxin-A for the Treatment of Sialorrhoea in Patients with Parkinson’s Disease.” Clinical Neurology and Neurosurgery 106 (March): 93–96. doi:10.1016/j.clineuro.2003.10.012.